急性冠脉综合征患者冠脉介入治疗术后二级预防现况调查分析.docVIP

急性冠脉综合征患者冠脉介入治疗术后二级预防现况调查分析 李松华1Δ，李冬荣2Δ，陆阳1，陈少萍1，秦永文1*，赵仙先1* 1.第二军医大学长海医院心血管内科，上海 200433 2.上杭中医院364200 ［摘要目的 调查我院患者住院期间二级预防情况。方法 收集20.1.1-20011.12.31在我院行冠脉介入的的病史资料随访患者二级预防药物使用情况。结果例患者β受体阻滞剂%、68.9%和92.4%。出院后随访，术后1月、半年及1年时候，阿司匹林的使用比例为98.3%、95.8%和94.1%；ACEI/ARB的使用比例为72.3%、69.7%和63.4%；β受体阻滞剂%、62.2%和52.1%；他汀类药物使用比例为91.6%、88.7%和83.6%，男性患者未吸烟比例86.4%、77.9%和78.6%；女性患者未吸烟比例100%、98.8%和98.8%；血压控制比例93.3%、95.4%和94.3%；血糖控制比例98.3%、96.2%和97.5%。结论 ［关键词］急性冠脉综合征；经皮冠状动脉介入治疗；二级预防；指南 Investigation and analysis of secondary prevention for patients with acute coronary syndrome after percutaneous coronary intervention LI Song-hua1Δ,LI Dong-rong2Δ,LU Yang1, CHEN Shao-ping1, QIN Yong-wen1*, ZHAO Xian-xian1* 1. Department of Cardiovasology, Changhai Hospital，Second Military Medical University, Shanghai，2004332. Department of Cardiology, Chinese Medicine Hospital，hanghang 364200，Fujian，China [Abstract] Objective To investigate the status of secondary prevention in patients with acute coronary syndrome received percutaneous coronary intervention(PCI) during hospitalization and after discharge. Methods We collected the information of patients with acute coronary syndrome undergoing PCI in our hospital from Jan 1st, 2009 to Dec 31nd, 2011, and investigated and analyzed the conditions of secondary prevention and drugs therapies for patients after discharge through outpatient or telephone follow-up mode. Results The study analyzed 238 cases of patients with acute coronary syndrome received PCI.During hospitalization, smoking patients were forced to quit cigarettes, and using proportion of aspirin, ACEI/ARB, β-blockers and statins among these patients were respective 96.6%, 73.1%, 68.9% and 92.4%. After discharge, using proportion of aspirin among these patients was respective 98.3%, 95.8% and 94.1% in 1 month, six months and 1 year after operation; and that of ACEI/ARB was respective 72.3%, 69.7% and 63.4%; and that of β-blockers was respective 68.1%, 62.2% and 52.1%; and that of statins was res